Why is Dr. N. Anthony Coles not seeking re-election?

The filing states that Dr. Coles informed the company of his decision not to stand for re-election. The specific reasons for his decision are not detailed in this 8-K filing.

Will Dr. Coles' departure impact McKesson's operations or financial performance?

This 8-K filing reports a change in board composition, which is a governance matter. It does not provide information suggesting any immediate impact on McKesson's operational or financial performance. His service continues until the annual meeting.

When will Dr. Coles' tenure on the board officially end?

Dr. Coles' tenure as a director and in his committee roles will end at McKesson's 2021 Annual Meeting, which is scheduled to be held on July 23, 2021.

What is the significance of the Regulation FD disclosure?

A Regulation FD disclosure ensures that material non-public information is broadly disseminated to all investors at the same time. In this case, it pertains to the announcement of Dr. Coles' decision not to seek re-election. While furnished to the SEC, it's not considered 'filed' for Section 18 liability.

MCK 8-K: Leadership Changes & Regulation FD

Summary

McKesson Corporation (MCK) filed an 8-K on April 19, 2021, reporting a significant change in its Board of Directors. Dr. N. Anthony Coles, a director since 2014 and a member of both the Compensation and Finance Committees, has informed the company that he will not seek re-election at the upcoming 2021 Annual Meeting scheduled for July 23, 2021. Dr. Coles will continue to serve in his current capacities until the Annual Meeting. The company has acknowledged his contributions and expressed gratitude for his service. This announcement, made via a press release filed as an exhibit, is primarily a disclosure of a routine board succession event. Investors should note that this is not indicative of any immediate operational or financial changes for McKesson, but rather a standard update regarding board composition.

Key Highlights

1Dr. N. Anthony Coles will not stand for re-election to the Board of Directors at the 2021 Annual Meeting.
2Dr. Coles has been a director since 2014 and serves on the Compensation and Finance Committees.
3He will continue his board and committee service until the Annual Meeting on July 23, 2021.
4The company expressed appreciation for Dr. Coles' service.
5The information was disclosed via a press release filed with the SEC as an exhibit.
6This is a Regulation FD disclosure, meaning the information is furnished but not deemed "filed" for liability purposes under Section 18 of the Exchange Act.

MCKESSON CORP 8-K Report, Executive Changes (Apr 19, 2021)

Summary

Key Highlights

Frequently Asked Questions